These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4586970)

  • 41. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.
    Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC
    Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599
    [No Abstract]   [Full Text] [Related]  

  • 42. [Catecholamine excretion and treatment of parkinsonism with midantan].
    Kandel' EI; Iadgarov IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1323-6. PubMed ID: 1015136
    [No Abstract]   [Full Text] [Related]  

  • 43. A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
    Dom R; Van Lommel R; Baro F
    Acta Psychiatr Scand; 1971; 47(4):399-410. PubMed ID: 4947805
    [No Abstract]   [Full Text] [Related]  

  • 44. [Long-time therapy of Parkinsonism with amantadine sulfate. Reply to L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsonism"].
    Fünfgeld EW
    Munch Med Wochenschr; 1972 Jun; 114(22):1064-5. PubMed ID: 5068021
    [No Abstract]   [Full Text] [Related]  

  • 45. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
    [No Abstract]   [Full Text] [Related]  

  • 46. [Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism].
    Presthus J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2119. PubMed ID: 4773985
    [No Abstract]   [Full Text] [Related]  

  • 47. Corneal endothelial dysfunction associated with amantadine toxicity.
    Chang KC; Kim MK; Wee WR; Lee JH
    Cornea; 2008 Dec; 27(10):1182-5. PubMed ID: 19034138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Amantadine for parkinsonism].
    Flatberg P
    Tidsskr Nor Laegeforen; 1970 May; 90(10):1101-2. PubMed ID: 5450047
    [No Abstract]   [Full Text] [Related]  

  • 49. The comparative value of amantadine and levodopa.
    Dallos V; Heathfield K; Stone P; Allen F
    Postgrad Med J; 1972 Jun; 48(560):354-8. PubMed ID: 4558895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Adamantylamine sulfate--a drug for treatment of Parkinson's disease with a new working principle].
    Fünfgeld EW
    Med Klin; 1970 Sep; 65(39):1703-6. PubMed ID: 5474341
    [No Abstract]   [Full Text] [Related]  

  • 51. Amantadine hydrochloride in the treatment of Parkinson's disease.
    Nagaswami S; Ranjini R
    J Kans Med Soc; 1971 Nov; 72(11):465-8. PubMed ID: 5120698
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of parkinsonism by amantadine and levodopa.
    Mawdsley C; Williams IR; Pullar IA; Davidson DL; Kinloch NE
    Clin Pharmacol Ther; 1972; 13(4):575-83. PubMed ID: 4557584
    [No Abstract]   [Full Text] [Related]  

  • 53. [Amantadine. Prolonged clinical trial in 50 parkinsonian patients].
    Castaigne P; Laplane D; Dordain G
    Nouv Presse Med; 1972 Feb; 1(8):533-6. PubMed ID: 5012351
    [No Abstract]   [Full Text] [Related]  

  • 54. Safety and efficacy of prolonged treatment with Tremblex (dexetimide), an antiparkinsonian agent. A controlled study.
    Zwanikken GJ; Oei TT; Kimya S; Amery W
    Acta Psychiatr Belg; 1976 May; 76(3):467-9. PubMed ID: 1020682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An evaluation of tofenacine (elamol), a new drug for the treatment of depression.
    Bram G; Shanmuganathan N
    Curr Ther Res Clin Exp; 1971 Oct; 13(10):625-30. PubMed ID: 5004800
    [No Abstract]   [Full Text] [Related]  

  • 56. [Amantadine in the treatment of Parkinson's syndrome: studied in 31 patients for 3 months].
    Campanella G; Zallone E; Buscaino GA
    Acta Neurol (Napoli); 1972; 27(5):491-500. PubMed ID: 4564842
    [No Abstract]   [Full Text] [Related]  

  • 57. Amantadine therapy in parkinsonism.
    Forssman B; Kihlstrand S; Larsson LE
    Acta Neurol Scand; 1972; 48(1):1-18. PubMed ID: 4553409
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment with midantan of patients with parkinsonism].
    Kadykov AS
    Sov Med; 1973 Sep; 36(9):143. PubMed ID: 4756486
    [No Abstract]   [Full Text] [Related]  

  • 59. [Amantadine hydrochloride in the treatment of Parkinson's syndrome].
    De la Herrán J; Figuerido JA
    Rev Esp Otoneurooftalmol Neurocir; 1971; 29(167):45-9. PubMed ID: 5091472
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical evaluation of amantadine therapy for parkinsonism and the side effects--in cases of thalamic surgery and L-dopa therapy.
    Matsumoto K; Omoto T; Beck H
    Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):1-10. PubMed ID: 4406943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.